Jones J, Patel B N, Skidmore C J
Department of Biochemistry & Physiology, University of Reading, Whiteknights, UK.
Carcinogenesis. 1988 Nov;9(11):2023-6. doi: 10.1093/carcin/9.11.2023.
Benzamides are potent inhibitors of nuclear ADP-ribosyltransferase and have been extensively used to demonstrate the involvement of ADP-ribosylation in cellular function. When permeabilized L1210 cells are treated with 50 microM 3-acetylamidobenzamide (3-aab) the enzyme is inhibited. However, when 50 nM 3-aab is used a two-fold stimulation of enzyme activity is produced. This anomalous stimulation is obtained with benzamides and nicotinamides and is correlated with their activity as inhibitors. Strikingly the steady-state level of poly(ADP-ribose) in intact cells is increased by these low levels of inhibitors. The mechanisms of this effect and its consequences for the experimental use of benzamides are discussed.
苯甲酰胺是核ADP-核糖基转移酶的强效抑制剂,已被广泛用于证明ADP-核糖基化参与细胞功能。当用50微摩尔3-乙酰氨基苯甲酰胺(3-aab)处理通透的L1210细胞时,该酶受到抑制。然而,当使用50纳摩尔3-aab时,会产生两倍的酶活性刺激。这种异常刺激在苯甲酰胺和烟酰胺中都能观察到,并且与它们作为抑制剂的活性相关。令人惊讶的是,这些低水平的抑制剂会提高完整细胞中聚(ADP-核糖)的稳态水平。本文讨论了这种效应的机制及其对苯甲酰胺实验应用的影响。